瘘管优先策略是否仍然有效?
该数据集讨论瘘管优先策略在血液透析患者中的有效性,比较动静脉瘘与动静脉移植物的优劣。

基本信息
资源简介
瘘管优先策略是否仍然有效?
【一句话概览】
本数据集是 figshare 公开的文本数据集,收录 2 个文件、合计 11.26 KB,主题涵盖 Dialysis、Renal Dialysis、Fistula、Arteriovenous fistula、Nephrology,可用于医学自然语言处理(实体识别、信息抽取等),CC BY 4.0 许可开放获取。
【数据集背景】
本数据集源站标题为《Is the Fistula First Approach still valid?》。配套论文《Is the Fistula First Approach still valid?》发表于 Brazilian Journal of Nephrology(2021),DOI:10.1590/2175-8239-jbn-2020-u001。源站首次发布:2022-05-27。
【数据内容】
源站原始描述:ABSTRACT The Fistula First Breakthrough Initiative, founded in 2003, was responsible for changing the access profile in the United States, increasing the prevalence of arteriovenous fistulas (AVFs) by 50% and reducing that of arteriovenous grafts (AVGs). However, the concept that AVFs are always the best access for all patients has been challenged. Discussion points are: (1) the questionable survival benefit of AVFs over AVGs, if one takes into account the high rates of primary AVF failure; (2)…
【数据结构与技术规格】
文件数 2 个,合计 11.26 KB。数据集 DOI:10.6084/m9.figshare.19899950.v1。
【主题与分类】
源站学科分类:Nephrology and Urology。主题标签:Dialysis、Renal Dialysis、Fistula、Arteriovenous fistula、Nephrology、Vascular Access Devices、Vascular Grafting。
【适用方向】
文本类数据可用于医学自然语言处理,如命名实体识别、信息抽取与文本分类。
【获取与许可】
源站页面:https://scielo.figshare.com/articles/dataset/Is_the_Fistula_First_Approach_still_valid_/19899950
使用许可:CC BY 4.0(https://creativecommons.org/licenses/by/4.0/)。
规范引用:Franco, Ricardo Portiolli (2021). Is the Fistula First Approach still valid?. SciELO journals. Dataset
【使用注意】
· 源站最后修改于 2023-06-03,引用时请注意版本时效。
下载信息
注册下载
需要注册 Kaggle 账号并登录后下载,适合需要跟踪下载记录和使用 API 的用户。
暂未开放公开下载
无需注册即可直接获取公开样本或文档,适合快速预览和评估数据集质量。
免登录有偿下载
公开数据集受托下载与技术交付服务。
提供高速下载与技术交付服务(收技术服务费,非数据销售)
暂未开放当前数据集主要来源为 Kaggle 公开托管,完整影像包建议通过原始链接或 Kaggle API 获取。
使用方式
数据集获取(Figshare)
- 源站标题:Is the Fistula First Approach still valid?
- DOI:10.6084/m9.figshare.19899950.v1
- 发布日期:2022-05-27
- 文件数:2 个
- 文件总体积:11.26 KB
- 源站页面:https://scielo.figshare.com/articles/dataset/Is_the_Fistula_First_Approach_still_valid_/19899950
命令行下载
curl -L -o "Table_1.xls" "https://ndownloader.figshare.com/files/35326475"
curl -L -o "Table_2.xls" "https://ndownloader.figshare.com/files/35326478"
文件清单
Table_1.xls(5.63 KB)Table_2.xls(5.63 KB)
文件总体积 11.26 KB(源站 API 实测)。
数据加载示例(图像类)
from PIL import Image
import glob, os
files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
+ glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
+ glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)
# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path) # 要求 子目录=类别
目录组织与标注格式以源站说明和下载后实际文件为准。
数据说明
ABSTRACT The Fistula First Breakthrough Initiative, founded in 2003, was responsible for changing the access profile in the United States, increasing the prevalence of arteriovenous fistulas (AVFs) by 50% and reducing that of arteriovenous grafts (AVGs). However, the concept that AVFs are always the best access for all patients has been challenged. Discussion points are: (1) the questionable survival benefit of AVFs over AVGs, if one takes into account the high rates of primary AVF failure; (2) the potential benefits of using AVGs for greater primary success; and (3) the questionable benefit of AVFs over AVGs in patients with shorter survival, such as the elderly. The high rate of primary failure and maturation procedures leads to prolonged use of catheters, and it is one of the weaknesses of the fistula first strategy. AVGs proved to be better than AVFs as a second access after the failure of a first AVF, and in patients with non-ideal vessels, with greater primary success and reduced catheter times. AVGs appear to have a similar survival to AVFs in patients older than 80 years, with less primary failures and interventions to promote maturation. The most recent KDOQUI guidelines suggest an individualized approach in access planning, taking into account life expectancy, comorbidities and individual vascular characteristics, with the aim of chosing adequate access for the right patient, at the right time, for the right reasons.
许可
CC BY 4.0
引用
学术使用请引用 DOI 10.6084/m9.figshare.19899950.v1(source: https://scielo.figshare.com/articles/dataset/Is_the_Fistula_First_Approach_still_valid_/19899950)。
数据缺失?
依托陕西、四川两大基地,我们与超过十家三甲医院建立直接合作关系,覆盖合规授权、采集治理、专业标注、数据交付的全流程,为AI医疗团队提供即拿即用的高质量临床数据。
⚡️ 需要数据支持或标注服务?立即联系我们获取专业方案。




